Advances in leishmaniasis.
Explore this paper's citation graph
Summary
Governed by parasite and host factors and immunoinflammatory responses, the clinical spectrum of leishmaniasis encompasses subclinical (inapparent), localised (skin lesions), and disseminated infection (cutaneous, mucosal, or visceral).
- Type
- review
- Published
- 2005-10-29
- Cited by
- 1,775
- References
- 195
- OpenAlex
- https://openalex.org/W2170956456
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:2523912
Keywords
Paromomycin, Miltefosine, Visceral leishmaniasis, Immunology, Leishmaniasis
References
- Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial.
- Leishmaniasis host response loci (lmr1–3) modify disease severity through a Th1/Th2-independent pathway
- Novel Program of Macrophage Gene Expression Induced by Phagocytosis of Leishmania chagasi
- Therapy of Venezuelan patients with severe mucocutaneous or early lesions of diffuse cutaneous leishmaniasis with a vaccine containing pasteurized Leishmania promastigotes and bacillus Calmette-Guerin: preliminary report.
- Cutaneous leishmaniasis: clinical aspect.
- Old World leishmaniasis.
- The world's most neglected diseases
- [Change in human visceral leishmaniasis treatment in Italy: retrospective study of 630 patients].
- Treatment of cutaneous leishmaniasis with antimony: intramuscular versus intralesional administration.
- Kala-azar: a potentially eradicable disease as a public health challenge.
- Characterization of the humoral immune response in Sudanese leishmaniasis: specific antibody detected by class- and subclass-specific reagents.
- Leishmania–sand fly interactions controlling species‐specific vector competence
- Circulating T helper 1 (Th1) cell- and Th2 cell-associated cytokines in Indian patients with visceral leishmaniasis.
- Activation of TGF-β by Leishmania chagasi: Importance for Parasite Survival in Macrophages 1
- Diagnosis of Cutaneous Leishmaniasis in Colombia: the Sampling Site within Lesions Influences the Sensitivity of Parasitologic Diagnosis
- Leishmaniasis: new approaches to disease control
- Second-generation vaccines against leishmaniasis.
- Diagnosis of visceral leishmaniasis: the sensitivities and specificities of traditional methods and a nested PCR assay
- New perspectives on a subclinical form of visceral leishmaniasis.
- Convenience of Serum for Visceral Leishmaniasis Diagnosis by PCR
Cited by
- Fishing for anti-leishmania drugs: principles and problems.
- Chemistry and Leishmanicidal Activity of the Essential Oil from Artemisia absinthium from Cuba
- Immunological Determinants of Clinical Outcome in Peruvian Patients with Tegumentary Leishmaniasis Treated with Pentavalent Antimonials
- 115 kDa serine protease confers sustained protection to visceral leishmaniasis caused by Leishmania donovani via IFN-γ induced down-regulation of TNF-α mediated MMP-9 activity.
- Regulatory T Cells in the Pathogenesis and Healing of Chronic Human Dermal Leishmaniasis Caused by Leishmania (Viannia) Species
- Assessment of interferon-γ levels and leishmanin skin test results in persons recovered for leishmaniasis.
- Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis.
- Investigation of antileishmanial activities of Tio2@Ag nanoparticles on biological properties of L. tropica and L. infantum parasites, in vitro.
- Molecular mechanism underlying antileishmanial effect of oxabicyclo[3.3.1]nonanones: inhibition of key redox enzymes of the pathogen.
- Chronic arsenic exposure and microbial drug resistance
- Deficiency of p110δ Isoform of the Phosphoinositide 3 Kinase Leads to Enhanced Resistance to Leishmania donovani
- Studies on cocktails of 31‐kDa, 36‐kDa and 51‐kDa antigens of Leishmania donovani along with saponin against murine visceral leishmaniasis
- Epigenetics: A New Model for Intracellular Parasite-Host Cell Regulation.
- Effect of hydroalcoholic extract of Echinacea purpurea in combination with meglumine antimoniate on treatment of Leishmania major-induced cutaneous leishmaniasis in BALB/c mice
- Liposomal formulations in the pharmacological treatment of leishmaniasis: a review
- Vaccination with poly(D,L-lactide-co-glycolide) nanoparticles loaded with soluble Leishmania antigens and modified with a TNFα-mimicking peptide or monophosphoryl lipid A confers protection against experimental visceral leishmaniasis
- Molecular Diagnosis of Clinical Isolates of Cutaneous Leishmaniasis Using ITS1 and KDNA Genes and Genetic Polymorphism of Leishmania in Kashan, Iran.
- Kutane Leishmaniasis als Reisedermatose
- Elucidating the Role of Macrophages in Visceral Leishmaniasis
- Bioactivity-Guided Fractionation of Taxodium distichum
Related papers
- Combined treatment of miltefosine and paromomycin delays the onset of experimental drug resistance in Leishmania infantum
- Visceral leishmaniasis (kala-azar): challenges ahead.
- Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?
- A rare case of Visceral leishmaniasis with multiple relapse and multi-drug unresponsive: successfully treated with combination therapy
- Leishmaniasis
- Current treatment of visceral leishmaniasis (Kala-azar): an overview
- Can a simple outpatient‐based treatment be used to treat cutaneous leishmaniasis in young children? A Critically Appraised Topic
- Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?
- Treatment of visceral leishmaniasis (kala-azar): a decade of progress and future approaches.
- [Management of cutaneous leishmaniasis in adults and children].